EMEA (Europe, Middle East and Africa) Weight Loss Drugs Market Report 2017

December 2017 | 113 pages | ID: E3FEAA538F1EN
QYResearch

Abstracts

In this report, the EMEA Weight Loss Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Weight Loss Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Weight Loss Drugs market competition by top manufacturers/players, with Weight Loss Drugs sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Roche
• GSK group
• Teva
• Sandoz(Novartis)
• STADA-VN J.V.Co., Ltd
• Hexal AG
• National Company For Pharmaceutical Industry
• Lunan Pharmaceutical Group Corporation
• Zein Pharmaceutical
• Hisun
• Taj Pharmaceuticals Ltd
• Kabir Life Sciences & Research
• Dm Pharma
• China Zhongshan Pharm

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Liauid
• Tablets

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Weight-reducing Aid
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Weight Loss Drugs Market Report 2017

1 WEIGHT LOSS DRUGS OVERVIEW

1.1 Product Overview and Scope of Weight Loss Drugs
1.2 Classification of Weight Loss Drugs
  1.2.1 EMEA Weight Loss Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Weight Loss Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Liauid
  1.2.4 Tablets
1.3 EMEA Weight Loss Drugs Market by Application/End Users
  1.3.1 EMEA Weight Loss Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Weight-reducing Aid
  1.3.3 Other
1.4 EMEA Weight Loss Drugs Market by Region
  1.4.1 EMEA Weight Loss Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Weight Loss Drugs (2012-2022)
  1.5.1 EMEA Weight Loss Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Weight Loss Drugs Revenue and Growth Rate (2012-2022)

2 EMEA WEIGHT LOSS DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Weight Loss Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Weight Loss Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Weight Loss Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Weight Loss Drugs Sale Price by Players (2012-2017)
2.2 EMEA Weight Loss Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Weight Loss Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Weight Loss Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Weight Loss Drugs Sale Price by Type (2012-2017)
2.3 EMEA Weight Loss Drugs (Volume) by Application
2.4 EMEA Weight Loss Drugs (Volume and Value) by Region
  2.4.1 EMEA Weight Loss Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Weight Loss Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Weight Loss Drugs Sales Price by Region (2012-2017)

3 EUROPE WEIGHT LOSS DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Weight Loss Drugs Sales and Value (2012-2017)
  3.1.1 Europe Weight Loss Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Weight Loss Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Weight Loss Drugs Sales and Market Share by Type
3.3 Europe Weight Loss Drugs Sales and Market Share by Application
3.4 Europe Weight Loss Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Weight Loss Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe Weight Loss Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany Weight Loss Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France Weight Loss Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK Weight Loss Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia Weight Loss Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy Weight Loss Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Weight Loss Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST WEIGHT LOSS DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Weight Loss Drugs Sales and Value (2012-2017)
  4.1.1 Middle East Weight Loss Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Weight Loss Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Weight Loss Drugs Sales and Market Share by Type
4.3 Middle East Weight Loss Drugs Sales and Market Share by Application
4.4 Middle East Weight Loss Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Weight Loss Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Weight Loss Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Weight Loss Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel Weight Loss Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE Weight Loss Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran Weight Loss Drugs Sales and Growth Rate (2012-2017)

5 AFRICA WEIGHT LOSS DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Weight Loss Drugs Sales and Value (2012-2017)
  5.1.1 Africa Weight Loss Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Weight Loss Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Weight Loss Drugs Sales and Market Share by Type
5.3 Africa Weight Loss Drugs Sales and Market Share by Application
5.4 Africa Weight Loss Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Weight Loss Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa Weight Loss Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa Weight Loss Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Weight Loss Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Weight Loss Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Weight Loss Drugs Sales and Growth Rate (2012-2017)

6 EMEA WEIGHT LOSS DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Roche
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Weight Loss Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Roche Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GSK group
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Weight Loss Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GSK group Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Teva
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Weight Loss Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Teva Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sandoz(Novartis)
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Weight Loss Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sandoz(Novartis) Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 STADA-VN J.V.Co., Ltd
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Weight Loss Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 STADA-VN J.V.Co., Ltd Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Hexal AG
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Weight Loss Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Hexal AG Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 National Company For Pharmaceutical Industry
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Weight Loss Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 National Company For Pharmaceutical Industry Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Lunan Pharmaceutical Group Corporation
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Weight Loss Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Lunan Pharmaceutical Group Corporation Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Zein Pharmaceutical
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Weight Loss Drugs Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Zein Pharmaceutical Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Hisun
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Weight Loss Drugs Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Hisun Weight Loss Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Taj Pharmaceuticals Ltd
6.12 Kabir Life Sciences & Research
6.13 Dm Pharma
6.14 China Zhongshan Pharm

7 WEIGHT LOSS DRUGS MANUFACTURING COST ANALYSIS

7.1 Weight Loss Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Weight Loss Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Weight Loss Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Weight Loss Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA WEIGHT LOSS DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA Weight Loss Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Weight Loss Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Weight Loss Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Weight Loss Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Weight Loss Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Weight Loss Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Weight Loss Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Weight Loss Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Weight Loss Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Weight Loss Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Weight Loss Drugs
Figure EMEA Weight Loss Drugs Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Weight Loss Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Liauid Product Picture
Figure Tablets Product Picture
Figure EMEA Weight Loss Drugs Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Weight Loss Drugs by Application in 2016
Figure Weight-reducing Aid Examples
Table Key Downstream Customer in Weight-reducing Aid
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Weight Loss Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Weight Loss Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Weight Loss Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Weight Loss Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Weight Loss Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Weight Loss Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Weight Loss Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Weight Loss Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Weight Loss Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Weight Loss Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Weight Loss Drugs Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Weight Loss Drugs Sales Share by Players (2012-2017)
Figure 2016 Weight Loss Drugs Sales Share by Players
Figure 2017 Weight Loss Drugs Sales Share by Players
Figure EMEA Weight Loss Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Weight Loss Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Weight Loss Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Weight Loss Drugs Revenue Share by Players
Table 2017 EMEA Weight Loss Drugs Revenue Share by Players
Table EMEA Weight Loss Drugs Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Weight Loss Drugs Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Weight Loss Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Weight Loss Drugs by Type (2012-2017)
Figure EMEA Weight Loss Drugs Sales Market Share by Type (2012-2017)
Table EMEA Weight Loss Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Weight Loss Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Weight Loss Drugs by Type in 2016
Table EMEA Weight Loss Drugs Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Weight Loss Drugs Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Weight Loss Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Weight Loss Drugs by Application (2012-2017)
Figure EMEA Weight Loss Drugs Sales Market Share by Application in 2016
Table EMEA Weight Loss Drugs Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Weight Loss Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Weight Loss Drugs by Region (2012-2017)
Figure EMEA Weight Loss Drugs Sales Market Share in 2016
Table EMEA Weight Loss Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Weight Loss Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Weight Loss Drugs by Region (2012-2017)
Figure EMEA Weight Loss Drugs Revenue Market Share Regions in 2016
Table EMEA Weight Loss Drugs Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Weight Loss Drugs Revenue and Growth Rate (2012-2017)
Table Europe Weight Loss Drugs Sales (K Units) by Type (2012-2017)
Table Europe Weight Loss Drugs Market Share by Type (2012-2017)
Figure Europe Weight Loss Drugs Market Share by Type in 2016
Table Europe Weight Loss Drugs Sales (K Units) by Application (2012-2017)
Table Europe Weight Loss Drugs Market Share by Application (2012-2017)
Figure Europe Weight Loss Drugs Market Share by Application in 2016
Table Europe Weight Loss Drugs Sales (K Units) by Countries (2012-2017)
Table Europe Weight Loss Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Weight Loss Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Weight Loss Drugs Sales Market Share by Countries in 2016
Table Europe Weight Loss Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Weight Loss Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Weight Loss Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Weight Loss Drugs Revenue Market Share by Countries in 2016
Figure Germany Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure France Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UK Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Weight Loss Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Weight Loss Drugs Sales (K Units) by Type (2012-2017)
Table Middle East Weight Loss Drugs Market Share by Type (2012-2017)
Figure Middle East Weight Loss Drugs Market Share by Type (2012-2017)
Table Middle East Weight Loss Drugs Sales (K Units) by Applications (2012-2017)
Table Middle East Weight Loss Drugs Market Share by Applications (2012-2017)
Figure Middle East Weight Loss Drugs Sales Market Share by Application in 2016
Table Middle East Weight Loss Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Weight Loss Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Weight Loss Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Weight Loss Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Weight Loss Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Weight Loss Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Weight Loss Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Weight Loss Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Weight Loss Drugs Sales (K Units) by Type (2012-2017)
Table Africa Weight Loss Drugs Sales Market Share by Type (2012-2017)
Figure Africa Weight Loss Drugs Sales Market Share by Type (2012-2017)
Figure Africa Weight Loss Drugs Sales Market Share by Type in 2016
Table Africa Weight Loss Drugs Sales (K Units) by Application (2012-2017)
Table Africa Weight Loss Drugs Sales Market Share by Application (2012-2017)
Figure Africa Weight Loss Drugs Sales Market Share by Application (2012-2017)
Table Africa Weight Loss Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Africa Weight Loss Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Weight Loss Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Weight Loss Drugs Sales Market Share by Countries in 2016
Table Africa Weight Loss Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Weight Loss Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Weight Loss Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Weight Loss Drugs Revenue Market Share by Countries in 2016
Figure South Africa Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Roche Weight Loss Drugs Basic Information List
Table Roche Weight Loss Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Roche Weight Loss Drugs Sales Market Share in EMEA (2012-2017)
Figure Roche Weight Loss Drugs Revenue Market Share in EMEA (2012-2017)
Table GSK group Weight Loss Drugs Basic Information List
Table GSK group Weight Loss Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK group Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure GSK group Weight Loss Drugs Sales Market Share in EMEA (2012-2017)
Figure GSK group Weight Loss Drugs Revenue Market Share in EMEA (2012-2017)
Table Teva Weight Loss Drugs Basic Information List
Table Teva Weight Loss Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Teva Weight Loss Drugs Sales Market Share in EMEA (2012-2017)
Figure Teva Weight Loss Drugs Revenue Market Share in EMEA (2012-2017)
Table Sandoz(Novartis) Weight Loss Drugs Basic Information List
Table Sandoz(Novartis) Weight Loss Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sandoz(Novartis) Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Sandoz(Novartis) Weight Loss Drugs Sales Market Share in EMEA (2012-2017)
Figure Sandoz(Novartis) Weight Loss Drugs Revenue Market Share in EMEA (2012-2017)
Table STADA-VN J.V.Co., Ltd Weight Loss Drugs Basic Information List
Table STADA-VN J.V.Co., Ltd Weight Loss Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure STADA-VN J.V.Co., Ltd Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure STADA-VN J.V.Co., Ltd Weight Loss Drugs Sales Market Share in EMEA (2012-2017)
Figure STADA-VN J.V.Co., Ltd Weight Loss Drugs Revenue Market Share in EMEA (2012-2017)
Table Hexal AG Weight Loss Drugs Basic Information List
Table Hexal AG Weight Loss Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hexal AG Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Hexal AG Weight Loss Drugs Sales Market Share in EMEA (2012-2017)
Figure Hexal AG Weight Loss Drugs Revenue Market Share in EMEA (2012-2017)
Table National Company For Pharmaceutical Industry Weight Loss Drugs Basic Information List
Table National Company For Pharmaceutical Industry Weight Loss Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure National Company For Pharmaceutical Industry Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure National Company For Pharmaceutical Industry Weight Loss Drugs Sales Market Share in EMEA (2012-2017)
Figure National Company For Pharmaceutical Industry Weight Loss Drugs Revenue Market Share in EMEA (2012-2017)
Table Lunan Pharmaceutical Group Corporation Weight Loss Drugs Basic Information List
Table Lunan Pharmaceutical Group Corporation Weight Loss Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lunan Pharmaceutical Group Corporation Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Lunan Pharmaceutical Group Corporation Weight Loss Drugs Sales Market Share in EMEA (2012-2017)
Figure Lunan Pharmaceutical Group Corporation Weight Loss Drugs Revenue Market Share in EMEA (2012-2017)
Table Zein Pharmaceutical Weight Loss Drugs Basic Information List
Table Zein Pharmaceutical Weight Loss Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Zein Pharmaceutical Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Zein Pharmaceutical Weight Loss Drugs Sales Market Share in EMEA (2012-2017)
Figure Zein Pharmaceutical Weight Loss Drugs Revenue Market Share in EMEA (2012-2017)
Table Hisun Weight Loss Drugs Basic Information List
Table Hisun Weight Loss Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hisun Weight Loss Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Hisun Weight Loss Drugs Sales Market Share in EMEA (2012-2017)
Figure Hisun Weight Loss Drugs Revenue Market Share in EMEA (2012-2017)
Table Taj Pharmaceuticals Ltd Weight Loss Drugs Basic Information List
Table Kabir Life Sciences & Research Weight Loss Drugs Basic Information List
Table Dm Pharma Weight Loss Drugs Basic Information List
Table China Zhongshan Pharm Weight Loss Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Weight Loss Drugs
Figure Manufacturing Process Analysis of Weight Loss Drugs
Figure Weight Loss Drugs Industrial Chain Analysis
Table Raw Materials Sources of Weight Loss Drugs Major Manufacturers in 2016
Table Major Buyers of Weight Loss Drugs
Table Distributors/Traders List
Figure EMEA Weight Loss Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Weight Loss Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Weight Loss Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Weight Loss Drugs Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Weight Loss Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Weight Loss Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Weight Loss Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Weight Loss Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Weight Loss Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Weight Loss Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Weight Loss Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Weight Loss Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Weight Loss Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Weight Loss Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Weight Loss Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Weight Loss Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Weight Loss Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Weight Loss Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Weight Loss Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Weight Loss Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Weight Loss Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Weight Loss Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Weight Loss Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources